Detection of translocations involving MYC at 8q24.1 in B-cell lineage malignancies (BCL) is important for diagnostic and prognostic purposes. However, routine detection of MYC translocations is often hampered by the wide variation in breakpoint location within the MYC region, particularly when a gene other than IGH, such as IGK or IGL, is involved. To address this issue, we developed and validated four fluorescence in situ hybridization (FISH) probes: two break apart probes to detect IGK and IGL translocations, and two dualcolor, dual-fusion FISH (D-FISH) probes to detect IGK-MYC and IGL-MYC. MYC rearrangements (four IGK-MYC, 12 IGL-MYC and four unknown partner gene-MYC) were correctly identified in 20 of 20 archival BCL specimens known to have MYC rearrangements not involving IGH. Seven specimens, all of which lacked MYC rearrangements using a commercial IGH/MYC D-FISH probe, were found to have 8q24 breakpoints within a cluster region 4350-645 kb 3 0 from MYC, provisionally designated as Burkitt variant rearrangement region 2 (BVR2). FISH is a useful ancillary tool in identifying MYC rearrangements. In light of the discovery of the distally located BVR2 breakpoint cluster region, it is important to use MYC FISH probes that cover a breakpoint region at least 1.0 Mb 3 0 of MYC.
Introduction
The MYC-immunoglobulin (IG) gene rearrangements play a major role in the pathogenesis of B-cell lineage malignancy (BCL) by deregulation of MYC oncogene expression via juxtaposition to one of the immunoglobulin enhancers. The characteristic reciprocal translocations in Burkitt lymphoma (BL) involve the juxtaposition of the MYC oncogene on 8q24.1 and one of the IG gene loci: 14q32.3 (IGH) in approximately 75% of cases and 22q11.2 (IGL) or 2p11.2 (IGK) in the remainder. In non-Hodgkin lymphoma harboring IG-MYC translocations, the MYC translocation partner is IGH, IGL and IGK in approximately 70, 22 and 8% of cases, respectively. 1 All three translocations have been reported in several BCL other than BL including atypical Burkitt/Burkitt-like lymphoma (AB/BLL), 2 diffuse large B-cell lymphoma (DLBCL), 1, 3, 4 follicular lymphoma (FL), 1 mantle cell lymphoma (MCL) 5 and multiple myeloma (MM). [6] [7] [8] With the exception of childhood BL, MYC/8q24 abnormalities are usually indicators of an aggressive clinical course, being associated with a poor prognosis in DLBCL and FL, 1 a trend toward worse survival in AB/BLL 1,2 the blastoid variant and a poor prognosis in MCL 5 and clinically aggressive forms of MM. 8 Furthermore, BCL with concurrent t(14;18)(q32;q21)/IGH-BCL2 fusion and 8q24/c-MYC translocations are associated with an extremely poor outcome. 9, 10 Breakpoints on 8q24 vary widely in these translocations. In t(8;14)(q24.1;q32.3)/IGH-MYC-positive cases, breakpoints are scattered widely within the 8q24 and 14q32 loci. 7, 8, [11] [12] [13] [14] [15] In the variant t(8;22)(q24.1;q11.2)/IGL-MYC and t(2;8)(p11.2;q24.1)/ IGK-MYC rearrangements, breakpoints in 8q24 are consistently found 3 0 of MYC and may localize as far as 320 kb downstream toward the telomere. Corresponding breakpoints in the IGL and IGK loci generally occur within or near the joining region genes located 5 0 from immunoglobulin enhancers. [11] [12] [13] [16] [17] [18] Detection of MYC translocations is important for diagnostic and prognostic purposes, but on a routine basis it is hampered by technical issues. Conventional cytogenetics is limited by the need for fresh tissue and the difficulty in obtaining suitable metaphases from the neoplastic cells. Southern blot is slow and has limited sensitivity. Detection of MYC translocations by fluorescence in situ hybridization (FISH) using the commercially available dual-fusion FISH (D-FISH) IGH/MYC probe might not always be possible or lead to false-negative results, as some 8q24 breakpoints occur outside the region spanned by the relatively small (750 kb) locus-specific MYC probe. 8, 14 In addition, although many FISH methods have been described for detecting IGH translocations in BCL (for a review, see Willis and Dyer 19 ), there are comparably few assays for detecting IGL and IGK rearrangements. 20, 21 Consequently, most light-chain translocations are identified by conventional cytogenetics. However, because many BCL have low karyotypic yield and because conventional cytogenetics identifies chromosomal breakpoints but not specific genes, these methods cannot be relied upon to identify IGL or IGK translocations. To overcome these limitations, four highly sensitive and specific FISH probes were developed in our laboratory: two to detect chromosomal rearrangements involving the IGL and IGK genes, and two specifically to detect t(8;22)(q24.1;q11.2)/IGL-MYC and t(2;8)(p11.2;q24.1)/IGK-MYC. In the course of our investigations, we also identified a novel breakpoint cluster region associated with IG light chain-MYC gene translocations that is further downstream from the MYC oncogene than previously described.
Materials and methods

FISH probes
The details of bacterial artificial chromosome (BAC) clone search, BAC clone sources, preparation, descriptions and validation are provided in the Supplementary text. Table 1 summarizes homebrew and commercial FISH probes used in this study. IGK, IGL and MYC homebrew FISH probe designs using a schematic of gene structure and complementary BAC alignments are depicted in Figures 1-3 , respectively. Throughout this paper, SpectrumOrange-labeled signals are referred to as red (R), SpectrumGreen-labeled signals as green (G), SpectrumAqua-labeled signals as aqua (AQ) and SpectrumOrange-SpectrumGreen fusion signals as fusion (F).
Probe efficacy study
FISH was performed on fresh-fixed and paraffin-embedded tissue samples as described previously. [22] [23] [24] 
Identification of novel breakpoints in seven cases
In the probe efficacy study, all 20 clinical specimens were tested for a MYC rearrangement using two commercially available FISH probes: MYC BAP and MYC/IGH/CEP8 (Vysis, Downers Grove, IL, USA). Although all 20 clinical cases were positive for a MYC rearrangement using the MYC BAP, a subset of cases (seven of 20) failed to demonstrate a MYC rearrangement using the MYC/IGH/CEP8 probe set (see Supplementary Figure 2e -h). As IGK-MYC and IGL-MYC translocations involve 8q24 breakpoints 3 0 (downstream) from MYC 13 and the locus-specific commercial probe for the MYC locus extends 350 kb downstream from MYC, these results indicated that these seven cases (six IGL-MYC positive and one IGK-MYC positive) have 8q24 breakpoints greater than 350 kb telomeric (downstream) from MYC. Our initial pilot studies employed a prototype IGL-MYC probe consisting of locus-specific contigs spanning 743 and 950 kb, respectively (refer to Supplementary text for probe descriptions). Early testing of one of the seven cases in question (case 10, a t(8;22)(q24.1;q11.2)-positive BCL) with the IGL/MYC prototype produced a classic D-FISH (1R1G2F) signal pattern, but the two fusion signals were very unequal in size. Metaphase FISH localized the small fusion to the der(22)t(8;22)-(q24.1;q11.2) chromosome, indicating that the 8q24 breakpoint was likely within the most telomeric BAC (RP11-654O1). Likewise, as the minute truncated green signal associated with the IGL gene locus remained on the der(22)t(8;22)(q24.1;q11.2), the breakpoint on 22q11.2 was likely on the 5 0 (centromeric) end of the probe sequence (Figure 5a and b) . Consequently, much larger locus-specific probes for MYC and IGL were developed (2.774 Mb vs 950 kb and 1.84 Mb vs 743 kb, respectively).
To identify each gene breakpoint in all seven cases, two sets of homebrew BAP probes were designed for each locus.
Breakpoints within the gap flanked by centromeric and telomeric probe sets produced a 1R1G1F pattern, whereas breakpoints within the region spanned by the most centromeric (labeled in SpectrumOrange) or most telomeric (labeled in SpectrumGreen) probes yielded 2F1R and 2F1G patterns, respectively. Supplementary Table 4 summarizes probe names, loci, sizes, gaps and clone composition. All the MYC breakpoints were localized to a region 4350-645 kb downstream from the 3 0 end of MYC (two cases within clone RP11-654O1, 497-645 kb downstream; two cases within clone RP11-709E21, 401-469 kb downstream; and three cases within clone RP11-263C20, 4350-469 kb downstream). The IGL breakpoints were localized to variable region gene segments approximately 97-334 kb upstream (5 0 ) of the IGL enhancer (two cases within clone RP11-126O14, 97-217 kb upstream; two cases within a region overlapped by clones RP11-126O14 and CTD-3115E23, B220.5 kb upstream; and two cases within clone CTD-3115E23, 224-334 kb upstream) and the IGK breakpoint was . IGK variable gene segments of the duplicated distal copy are designated by the same numbers as corresponding genes in the proximal copy, with the letter D added. Orange and green bars depict complementary SpectrumOrange-labeled and SpectrumGreen-labeled BAC alignments, respectively. Orange dash marks represent crosshybridization of the SpectrumOrange-labeled centromeric probe used in the IGK BAP to the variable cluster of the proximal copy owing to high sequence homologies (described in Supplement). Small gaps in this region indicate where variable genes are absent in the distal [1] [2] [3] [4] [5] [6] [7] [8] [9] or proximal (6D41, 1D-41 and 1D-43) duplicated variable cluster regions. 80 Purple segments represent unrelated genes adjacent to the IGK locus spanned by telomeric BAC probes. IGK gene diagram derived (with permission) from IMGT, 80 NCBI databases and other published studies. [81] [82] [83] [84] [85] [86] localized to a region o50 kb upstream (5 0 ) of the intronic and 3 0 IGK enhancers (within clone RP11-601N4 2)/IGL-MYC-positive BCL. As the 8q24 breakpoints associated with this subset reside downstream from the region spanned by the locus-specific MYC probe in the commercial MYC/IGH/CEP8 set, BCL suspected of having a MYC rearrangement should be screened using a MYC BAP in which centromeric and telomeric probes flank a breakpoint region of at least 1.0 Mb 3 0 of MYC. Cases positive for a MYC rearrangement and negative for IGH-MYC fusions should then be tested for IGK-MYC and IGL-MYC gene rearrangements, using the appropriate probe sets with a locusspecific MYC probe spanning at least 500 kb centromeric and 1 Mb telomeric of the MYC gene sequence, bearing in mind that MYC translocations may involve partner loci other than IGH, IGK and IGL. 1, 4, 7, 8, [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] Twenty years ago, high-resolution banding methods were used to demonstrate that some 8q24 breakpoints associated with the variant t(8;22)(q24.1;q11.2)/IGL-MYC translocation were widely dispersed telomeric to the MYC oncogene and localized as far telomeric as 8q24. 22 . 55 1R1G1F  3R3G2AQ  2F  1R1G1F  1R1G2F  IGL-MYC   3   a   DLBCL  2R2G2F  4R4-6G4AQ  4F  NA  2R2G1F  2R1G4F  IGL-MYC  5  DLBCL  1R1G1F  3R2G2AQ  2F  1R1G1F  1R1G2F  IGL-MYC  15   a   DLBCL  1R1G1F  2R2G2AQ  1R1G1F  1R1G2F  2F  NA  IGK-MYC  20   a   AB/BLL  1R1G1F  2R3G2AQ  2F  1R1G1F  1R1G2F  IGL-MYC  22  AB/BLL  1R1G2F  4R4G2AQ  2F  NA  2F  NA  ?-MYC  23  AB/BLL  2R1G1F  3-4R3G3AQ  2F  2F  ?-MYC  24  DLBCL  3R1G1F  5-6R3G4AQ  2F  2F ?-MYC Abbreviations: AB/BLL, atypical Burkitt/Burkitt-like lymphoma; AQ, aqua; B-ALL, precursor B-lymphoblastic leukemia; BL, Burkitt lymphoma; DLBCL, diffuse large B-cell lymphoma; F, fusion; FISH, fluorescence in situ hybridization; G, green; MM, multiple myeloma; NA, not applicable; R, red; ?, unknown gene. For simplicity, only the predominant FISH patterns observed in each hybridization are indicated. a Cases with distal 8q24 breakpoints (4350-645 kb 3 0 from MYC oncogene). Table 3 Characterization In three cases, the 8q24 breakpoint was localized to the telomeric end of clone 263C20, in which an approximately 10 kb SpectrumOrangelabeled fragment was fused with an intact SpectrumGreen-labeled telomeric 8q24 probe. The distance of the 8q24 breakpoint in these cases is greater than 350 kb, and probably localized B391 kb downstream from MYC.
b IGL breakpoints in two cases localized to the region overlapped by clones 3115E23 and 126O14. approximately 11 kb within the PVT1 locus, which was termed the Burkitt variant rearrangement region 1 (BVR1) 17 ( Figure 6 ). Other investigators then used a variety of methods to map the breakpoints of both t (8;22) The sizeable distance of the immunoglobulin enhancers from MYC promoter sequences raises the possibility that genes other than MYC may be the targets of deregulation. A possible target identified in our study was the uncharacterized locus LOC441378, as all seven distal 8q24 breakpoints localized immediately 3 0 from this locus ( Figure 6 ). The genomic sequence of LOC441378 spans 56 kb within the 8q24, and is approximately 304 and 103 kb downstream from MYC and PVT1, respectively. Unfortunately, owing to sample limitations, MYC mRNA expression levels were not investigated in our study set. However, in a previous study, Northern blot analysis documented substantial expression of c-myc mRNA in 19 of 19 MM cell lines that had karyotypic abnormalities of MYC by FISH, including those with distal breakpoints studied by Fabris et al. 8 (SKMM-1 and KMS-11). Furthermore, in all previously studied cases of BL, only the rearranged MYC allele on the derivative 8 chromosome is expressed (typically at abnormally high levels), regardless of the location of the 8q24 breakpoint, whereas the normal allele is transcriptionally silent or expressed at an extremely low rate, 17, 18, [59] [60] [61] [62] [63] suggesting tumor-specific MYC deregulation, possibly facilitated by immunoglobulin regulatory elements.
Two plausible mechanisms for long distance deregulation of MYC expression are interstitial deletions and DNA looping. Interstitial deletions may put oncogenes and immunoglobulin regulatory elements into closer proximity by removing intervening sequences. However, it is unlikely that large interstitial deletions were present in the seven cases with distal 8q24 breakpoints as robust fusion signals associated with dual-fusion probe set hybridizations were consistently observed (Supplementary Figure 2) . A more likely mechanism for long distance oncogene deregulation is DNA looping. [64] [65] [66] [67] [68] Results from a recent study using a halo preparation/FISH technique on the t(2;8)(p11.2;q24.1)/IGK-MYC-positive LY66 BL cell line suggested that MYC and juxtaposed enhancer loci from the IGK gene may be brought into closer proximity by DNA folding via specific nuclear proteins, whereas intermediate DNA sequences are looped out. 57 A similar model of MYC deregulation in a transfected t(2;8)-positive BL cell line was also proposed. 69 Using BL cell lines transfected with IGK-MYC or IGL-MYC constructs, it has been shown that regulatory elements located immediately 5 0 from enhancer gene segments play crucial roles in promoter shift (P2-P1), 70 maximal MYC activation and subsequent MYC overexpression. [71] [72] [73] [74] [75] Located 5 0 from the intron and 3 0 IGK enhancers, the matrix association region has nuclear binding sites 69, 76, 77 as well as topoisomerase II sites 69 that may assist in facilitating chromatin arrangement and loop structures ultimately responsible for long distance oncogene deregulation as observed with MYC in IGK-MYC rearrangements. 72 Although less well understood, three DNAaseI hypersensitive sites 78,79 located 5 0 from the IGL enhancer are believed to play a similar role in MYC deregulation associated with IGL-MYC translocations. 75 FISH results from this small study set suggest that a significant proportion of MYC translocations in BCL may involve several uncharacterized partner genes. This mirrors a recent study of BCL karyotypically proven to have MYC translocations in which the MYC partner was an unknown (non-immunoglobulin) gene in 33% of cases. 1 Other studies have identified numerous karyotypes from BCL with reciprocal or complex translocations having breakpoints localized to 8q24 and a variety of non- Figure 5 Pilot study results using the prototype IGL/MYC probe on a known t(8;22)(q24.1;q11.2)-positive BCL (case 10). Prototype probe sizes were 950 kb for MYC (SpectrumOrange) and 743 kb for IGL (SpectrumGreen) (see Materials and methods for prototype descriptions). (a) Interphase FISH hybridization with IGL/MYC prototype probe depicting fusion signal size disparity. (b) Metaphase FISH hybridization in which arrows point to derivative 8 and 22 chromosomes. The tiny fusion signal on the der(22)t(8;22) (q24.1;q11.2) indicates that the 8q24 and 22q11.2 breakpoints are on the telomeric and centromeric ends of the locus-specific MYC and IGL probes, respectively. immunoglobulin partner loci. 1, [37] [38] [39] [40] [41] [42] Multicolor spectral karyotyping has been used to confirm breakpoints involving 8q24 in balanced and unbalanced rearrangements. 43, 44 Other studies utilized a combination of cytogenetics and either Southern blotting 4 or locus-specific FISH 7, 8, 45, 46 to confirm a MYC rearrangement involving unknown non-immunoglobulin partner genes. In contrast, only three MYC translocations involving nonimmunoglobulin loci have been described on a molecular level: t(8;14)(q24.1;q11)/MYC-TCRa, [47] [48] [49] [50] [51] [52] t(8;12)(q24.1;q22)/MYC-BTG1 53 and t(2;8)(q34;q24.1)/TCL4-MYC. 54 Our findings and those of the literature suggest that MYC-mediated oncogenesis can be induced by diverse molecular mechanisms that are more complex than previously recognized. 17 In this study, the seven cases with distal 8q24 breakpoints localized to a region 4350-645 kb downstream from MYC, provisionally designated BVR2. Based on our FISH results, BVR2 spans approximately 254 kb within a locus B 391 kb downstream (3 0 ) from the MYC oncogene.
